Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 25
2013 140
2014 83
2015 68
2016 67
2017 78
2018 77
2019 78
2020 68
2021 67
2022 90
2023 47

Text availability

Article attribute

Article type

Publication date

Search Results

854 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Editorial.
Parikh PM, Aggarwal S, Hingmire S. Parikh PM, et al. South Asian J Cancer. 2018 Apr-Jun;7(2):67-68. doi: 10.4103/sajc.sajc_144_18. South Asian J Cancer. 2018. PMID: 29721465 Free PMC article. No abstract available.
Tolvaptan.
Rangarajan B, Binoy V, Hingmire SS, Noronha V. Rangarajan B, et al. South Asian J Cancer. 2014 Jul;3(3):182-4. doi: 10.4103/2278-330X.136811. South Asian J Cancer. 2014. PMID: 25136528 Free PMC article.
Eribulin drug review.
Shetty N, Gupta S. Shetty N, et al. South Asian J Cancer. 2014 Jan;3(1):57-9. doi: 10.4103/2278-330X.126527. South Asian J Cancer. 2014. PMID: 24665449 Free PMC article. Review.
Eribulin is an anticancer drug approved for treatment of metastatic breast cancer. This drug is a synthetic derivative from Japanese marine sponge Halichondria okadai. It acts by interfering with the microtubular growth ultimately leading to apoptosis after prolonged mitot …
Eribulin is an anticancer drug approved for treatment of metastatic breast cancer. This drug is a synthetic derivative from Japanese …
First-line management of metastatic non-small cell lung cancer: An Indian perspective.
Ghadyalpatil NS, Pandey A, Krishnamani I, Srinivas C, Rafiq SJ, Hingmire SS, Maturu N, Reddy R, Kumar KK, Sreekanth K, Gurram BC, Parikh PM. Ghadyalpatil NS, et al. South Asian J Cancer. 2019 Apr-Jun;8(2):73-79. doi: 10.4103/sajc.sajc_294_18. South Asian J Cancer. 2019. PMID: 31069181 Free PMC article. Review.
Lung cancer has been the most common cancer in the world for several decades. The non-small cell lung cancer (NSCLC) constitutes approximately about 80% of the total cases of lung cancer. ...
Lung cancer has been the most common cancer in the world for several decades. The non-small cell lung cancer (NSCLC) co …
Hyperprogression after immunotherapy.
Abbas W, Rao RR, Popli S. Abbas W, et al. South Asian J Cancer. 2019 Oct-Dec;8(4):244-246. doi: 10.4103/sajc.sajc_389_18. South Asian J Cancer. 2019. PMID: 31807489 Free PMC article.
CONCLUSION: Hyperprogression was seen in 4 of 50 (8%) of patients, three of which had urothelial cancer and one malignant melanoma, treated with anti-PD-1 or anti-PD-L1 monotherapy. ...
CONCLUSION: Hyperprogression was seen in 4 of 50 (8%) of patients, three of which had urothelial cancer and one malignant melanoma, t …
Late effects of cancer treatment in breast cancer survivors.
Agrawal S. Agrawal S. South Asian J Cancer. 2014 Apr;3(2):112-5. doi: 10.4103/2278-330X.130445. South Asian J Cancer. 2014. PMID: 24818106 Free PMC article. Review.
Postoperative radiation therapy (RT) and chemotherapy,both reduces the risk of local recurrence and extends overall survival in patients with breast cancer (BC). Concerns have, however, been raised about the risk of acute and chronic side effects in breast cancer su …
Postoperative radiation therapy (RT) and chemotherapy,both reduces the risk of local recurrence and extends overall survival in patients wit …
Breast cancer: An overview of published Indian data.
Rangarajan B, Shet T, Wadasadawala T, Nair NS, Sairam RM, Hingmire SS, Bajpai J. Rangarajan B, et al. South Asian J Cancer. 2016 Jul-Sep;5(3):86-92. doi: 10.4103/2278-330X.187561. South Asian J Cancer. 2016. PMID: 27606288 Free PMC article. Review.
The Incidence of breast cancer has been steadily increasing in the last two decades, more so in urban areas of the sub-continent. Cancer ceters across the country have large numbers of patients being treated with multiple publications in this field. ...
The Incidence of breast cancer has been steadily increasing in the last two decades, more so in urban areas of the sub-continent. …
Angelina's choice.
Goel NS. Goel NS. South Asian J Cancer. 2013 Oct;2(4):285-7. doi: 10.4103/2278-330X.119903. South Asian J Cancer. 2013. PMID: 24455660 Free PMC article.
Lung cancer in the Indian subcontinent.
Noronha V, Pinninti R, Patil VM, Joshi A, Prabhash K. Noronha V, et al. South Asian J Cancer. 2016 Jul-Sep;5(3):95-103. doi: 10.4103/2278-330X.187571. South Asian J Cancer. 2016. PMID: 27606290 Free PMC article. Review.
Smoking tobacco, both cigarettes and beedis, is the principal risk factor for causation of lung cancer in Indian men; however, among Indian women, the association with smoking is not strong, suggesting that there could be other risk factors besides smoking. ...There is a l …
Smoking tobacco, both cigarettes and beedis, is the principal risk factor for causation of lung cancer in Indian men; however, among …
854 results